One cannabis trial covering the areas of Bern, Lucerne, and Biel, and another in Geneva, were recently approved in Switzerland.
According to a press release on May 10, the SCRIPT study (safer cannabis research in pharmacies randomized controlled trial) that will cover Bern, Lucerne and Biel received approval from the both the Swiss Federal Office of Public Health (BAG), the Cantonal Commission of Ethics and the Ethics Commission of Northwest and Central Switzerland.
Research will be conducted by the Bern Institute for Family Medicine at the University of Bern, which is expected to begin in October 2023-April 2026. The program
Read full article on High Times
